Serum amyloid A (SAA) Antibody (ML95), mAb, Mouse

SAA (ML95), mAb, Mouse

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.
V02007
¥20,887.00

Ask us a question
Description

Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.
Synonyms

Serum amyloid A (SAA) Antibody (ML95), mAb, Mouse

Note

GenScript can customize this product per customer's request including product size, buffer components, etc.

Overview
Subclass IgG1
Host Species Mouse
Conjugation Unconjugated
Antigen Species Human

Properties
Production Cultured in vitro under conditions free from animal-derived components
Purification Protein A/G affinity column
Formulation 1) PBS, pH 7.4, containing 0.03% Proclin 300
2) 50 mM Na-citrate, 150 mM NaCl, pH 7.0, containing 0.03% Proclin 300 *
*: For new batch since 09/01/2018, please refer to COA.
Concentration ≥2 mg/ml
Clone ID ML95
Recommended pairs TRFIA (Capture-Detection):
MLB2 - ML95
LETIA
MLB2 - ML95
ELISA (Capture-Detection):
MLB2 - 8C7
8C7 - 6F9
6F9 - 8C7
Storage For long term storage, aliquot and store at -20°C or below. Avoid repeated freezing and thawing cycles.

Applications
TRFIA/LTIA/ELISA

Background
Target Background Serum Amyloid A (SAA) is an acute-phase protein. The concentration of SAA in blood increases rapidly when tissue damage or inflammation occurs. It is considered as an early biomarker for the diagnosis of many inflammatory diseases. SAA can also be used as an important indicator of infection.